Literature DB >> 11260254

Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site.

K Hara1, M Shiota, H Kido, Y Ohtsu, T Kashiwagi, J Iwahashi, N Hamada, K Mizoue, N Tsumura, H Kato, T Toyoda.   

Abstract

BACKGROUND: Influenza virus RNA polymerase is a multifunctional enzyme that catalyses both transcription and replication of the RNA genome. The function of the influenza virus RNA polymerase PA subunit in viral replication is poorly understood, although the enzyme is known to be required for cRNA --> vRNA synthesis. The protease related activity of PA has been discussed ever since protease-inducing activity was demonstrated in transfection experiments.
RESULTS: PA protein was highly purified from insect cells infected with the recombinant baculovirus carrying PA cDNA, and a novel chymotrypsin-type serine protease activity was identified with the synthetic peptide, Suc-LLVY-MCA, in the PA protein. [3H]DFP was crosslinked with PA and a mutational analysis revealed that serine624 was as an active site for the protease activity.
CONCLUSIONS: These results constitute the demonstration of protease activity in PA subunit of the influenza virus RNA polymerase complexes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260254     DOI: 10.1046/j.1365-2443.2001.00399.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  27 in total

1.  A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs.

Authors:  Ervin Fodor; Louise J Mingay; Mandy Crow; Tao Deng; George G Brownlee
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses.

Authors:  Maite Huarte; Ana Falcón; Yuri Nakaya; Juan Ortín; Adolfo García-Sastre; Amelia Nieto
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 3.  Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms.

Authors:  Stéphane Boivin; Stephen Cusack; Rob W H Ruigrok; Darren J Hart
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

4.  Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription.

Authors:  Pablo Gastaminza; Beatriz Perales; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA.

Authors:  John F Regan; Yuying Liang; Tristram G Parslow
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.

Authors:  A Rodriguez; A Pérez-González; A Nieto
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

7.  Cellular protein HAX1 interacts with the influenza A virus PA polymerase subunit and impedes its nuclear translocation.

Authors:  Wei-Bin Hsu; Jia-Ling Shih; Jie-Ru Shih; Jia-Ling Du; Shu-Chun Teng; Li-Min Huang; Won-Bo Wang
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

Review 8.  Crucial role of PA in virus life cycle and host adaptation of influenza A virus.

Authors:  Jiao Hu; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2014-07-29       Impact factor: 3.402

Review 9.  The influenza virus RNA synthesis machine: advances in its structure and function.

Authors:  Patricia Resa-Infante; Núria Jorba; Rocio Coloma; Juan Ortin
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

10.  Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors.

Authors:  Birgit G Bradel-Tretheway; Jonelle L Mattiacio; Alexei Krasnoselsky; Catherine Stevenson; David Purdy; Stephen Dewhurst; Michael G Katze
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.